文献速递眼底病与葡萄膜炎

罕见与常见遗传变异、吸烟及体重指数与晚期年龄相关性黄斑变性进展及发病年龄的关系

Rare and Common Genetic Variants, Smoking, and Body Mass Index: Progression and Earlier Age of Developing Advanced Age-Related Macular Degeneration.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2020-01-01

在2976名年龄相关性眼病研究参与者(5421只非晚期AMD眼)中,纵向分析显示较高遗传风险评分与进展至晚期AMD风险增加相关,吸烟进一步增加该风险;吸烟使进展年龄提前3.9年,较高BMI提前1.7年,CFH R1201C、C3 K155Q和ARMS2/HTRA1变异与更早进展年龄相关。

要点

  • 较高遗传风险评分(含8个变异)与非晚期AMD进展至晚期风险增加相关,吸烟进一步增加风险。
  • 吸烟使进展至晚期AMD年龄提前3.9年,较高BMI提前1.7年,地理萎缩和新生血管病变结果相似。
  • CFH R1201C、C3 K155Q和ARMS2/HTRA1变异分别与进展年龄提前4.3年、2.15年和每等位基因0.8年相关。

核心结论

  • 补体通路罕见变异、ARMS2/HTRA1常见风险等位基因、吸烟和较高BMI可导致多达11.5年额外的疾病和治疗负担。
  • 更严格遵守健康生活方式可减少视力损害年数。

研究设计与样本

  • 纵向分析纳入年龄相关性眼病研究中2976名参与者(平均年龄68.8±5.0岁,56.1%女性)的5421只基线非晚期AMD眼。
  • 进展基于连续两次访视的AMD严重程度量表确认,分析调整眼间相关性、人口学和行为协变量、基线严重程度量表及遗传变异。

主要发现

  • 较高遗传风险评分(含8个遗传变异)与每个基线严重程度分层内进展至晚期AMD的更高发生率相关,尤其在最高风险的中度AMD类别。
  • 吸烟使进展至晚期AMD的年龄提前3.9年(P < 0.001),较高BMI使进展年龄提前1.7年(P = 0.003),地理萎缩和新生血管病变结果相似。
  • 与进展年龄提前相关的遗传变异为CFH R1201C(4.3年)、C3 K155Q(2.15年)和ARMS2/HTRA1(每等位基因0.8年)。

临床怎么用

  • 对非晚期AMD患者,评估吸烟和BMI等可改变因素,并考虑遗传风险评分以识别进展高风险个体。
  • 倡导健康生活方式(戒烟、控制体重)可能减少进展至晚期AMD的额外年数。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To determine behavioral and genetic factors associated with incidence and age of progression to advanced age-related macular degeneration (AMD), geographic atrophy (GA), and neovascular disease (NV), and to quantify these effects. METHODS: Longitudinal analyses were conducted among 5421 eyes with nonadvanced AMD at baseline in 2976 participants in the Age-Related Eye Disease Study (mean age of 68.8 (±5.0), 56.1% female). Progression was confirmed based on two consecutive visits on the AMD severity scale. Separate analyses for progression and age of progression were performed. All analyses adjusted for correlation between eyes, demographic and behavioral covariates, baseline severity scale, and genetic variants. RESULTS: A higher genetic risk score (GRS) including eight genetic variants was associated with a higher rate of progression to advanced AMD within each baseline severity scale, especially for the highest risk intermediate level AMD category, and smoking further increased this risk. When assessing age when progression to advanced disease occurred, smoking reduced age of onset by 3.9 years (P < 0.001), and higher body mass index (BMI) led to earlier onset by 1.7 years (P = 0.003), with similar results for GA and NV. Genetic variants associated with earlier age of progression were CFH R1201C (4.3 years), C3 K155Q (2.15 years), and ARMS2/HTRA1 (0.8 years per allele). CONCLUSIONS: Rare variants in the complement pathway and a common risk allele in ARMS2/HTRA1, smoking, and higher BMI can lead to as much as 11.5 additional years of disease and treatment burden. Closer adherence to healthy lifestyles could reduce years of visual impairment.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Seddon JM, Widjajahakim R, Rosner B, et al. Rare and Common Genetic Variants, Smoking, and Body Mass Index: Progression and Earlier Age of Developing Advanced Age-Related Macular Degeneration. Invest Ophthalmol Vis Sci. 2020. PMID: 33369641. doi:10.1167/iovs.61.14.32

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。